|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9323
|
|
pubmed:dateCreated |
2002-6-27
|
|
pubmed:abstractText |
Recombinant fibroblast growth factor-2 (rFGF-2) improves perfusion in models of myocardial and hindlimb ischaemia. We investigated whether one or two doses of intra-arterial rFGF-2 improves exercise capacity in patients with moderate-to-severe intermittent claudication.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
pubmed-author:AndersonR DavidRD,
pubmed-author:AnnexBrian HBH,
pubmed-author:HermillerJames BJB,
pubmed-author:HillegassWilliam BWB,
pubmed-author:LedermanRobert JRJ,
pubmed-author:MendelsohnFarrell OFO,
pubmed-author:MoonThomas ETE,
pubmed-author:Rocha-SinghKrishnaK,
pubmed-author:SaucedoJorge FJF,
pubmed-author:TRAFFIC Investigators,
pubmed-author:TenagliaAlan NAN,
pubmed-author:WhitehouseM JMJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
359
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2053-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12086757-Aged,
pubmed-meshheading:12086757-Analysis of Variance,
pubmed-meshheading:12086757-Double-Blind Method,
pubmed-meshheading:12086757-Drug Administration Schedule,
pubmed-meshheading:12086757-Female,
pubmed-meshheading:12086757-Fibroblast Growth Factor 2,
pubmed-meshheading:12086757-Humans,
pubmed-meshheading:12086757-Infusions, Intra-Arterial,
pubmed-meshheading:12086757-Intermittent Claudication,
pubmed-meshheading:12086757-Leg,
pubmed-meshheading:12086757-Male,
pubmed-meshheading:12086757-Neovascularization, Physiologic,
pubmed-meshheading:12086757-Treatment Outcome,
pubmed-meshheading:12086757-Walking
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.
|
|
pubmed:affiliation |
Division of Cardiology, University of Michigan Health System, Ann Arbor, MI, USA. lederman@nih.gov
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
